Transient receptor potential channel activation targets multiple stages of the schistosome parasite
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we describe a drug candidate, M5493, with potent activity against multiple parasite life cycle stages.
Limitation the authors admit
To circumvent its limited bioavailability, the active agent was converted to prodrug M5493, which displayed robust activity against the schistosome parasite at doses as low as 5 milligrams per kilogram in mice infected with Schistosoma mansoni .
Appeared: Friday, October 9. Science Translational Medicine. Peer-reviewed journal.